Related Experiment Video
Updated: May 12, 2026
11:32
Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
Posttranslational modifications regulate HIPK2, a driver of proliferative diseases
Vera V Saul1, M Lienhard Schmitz
1Department of Biochemistry, Justus Liebig University, Friedrichstrasse 24, 35392, Giessen, Germany.
Journal of Molecular Medicine (Berlin, Germany)
|April 26, 2013
Summary
Homeodomain-interacting protein kinase 2 (HIPK2) is a tumor suppressor regulating cell processes. Its dysregulation drives proliferative diseases like cancer and fibrosis.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Homeodomain-interacting protein kinase 2 (HIPK2) is a serine/threonine kinase with tumor-suppressive functions.
- HIPK2 is an evolutionarily conserved regulator of critical cellular signaling pathways and gene expression.
- Its functions span DNA damage response, apoptosis, hypoxia signaling, and cell proliferation.
Purpose of the Study:
- To review the multifaceted roles of HIPK2 in biological processes.
- To highlight the regulatory mechanisms controlling HIPK2 activity, including posttranslational modifications.
- To discuss the implications of HIPK2 dysregulation in the pathogenesis of proliferative diseases.
Main Methods:
- Literature review of recent studies on HIPK2.
- Analysis of HIPK2's involvement in various signaling pathways.
- Examination of posttranslational modifications affecting HIPK2.
Main Results:
- HIPK2 activity is tightly controlled by phosphorylation, SUMOylation, acetylation, and ubiquitination.
- Dysregulated HIPK2 contributes to uncontrolled cell proliferation observed in cancer and fibrosis.
- Inappropriate expression, modification, or localization of HIPK2 can drive disease progression.
Conclusions:
- HIPK2 is a crucial regulator of cell proliferation and survival.
- Aberrant HIPK2 function is implicated in the development of proliferative disorders.
- Understanding HIPK2 regulation offers potential therapeutic strategies for cancer and fibrosis.
Related Concept Videos
02:04Covalently Linked Protein Regulators
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
These groups modify specific amino acids in a protein.
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
02:39Positive Regulator Molecules
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.